261 related articles for article (PubMed ID: 32754278)
1. Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer.
Zhong W; Hou H; Liu T; Su S; Xi X; Liao Y; Xie R; Jin G; Liu X; Zhu L; Zhang H; Song X; Yang C; Sun T; Cao H; Wang B
Theranostics; 2020; 10(19):8790-8806. PubMed ID: 32754278
[No Abstract] [Full Text] [Related]
2. TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation.
Chen Z; He S; Zhan Y; He A; Fang D; Gong Y; Li X; Zhou L
EBioMedicine; 2019 Sep; 47():208-220. PubMed ID: 31420300
[TBL] [Abstract][Full Text] [Related]
3. Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner.
Elsafadi M; Manikandan M; Almalki S; Mahmood A; Shinwari T; Vishnubalaji R; Mobarak M; Alfayez M; Aldahmash A; Kassem M; Alajez NM
Cell Death Dis; 2020 May; 11(5):341. PubMed ID: 32393769
[TBL] [Abstract][Full Text] [Related]
4. TAGLN suppresses proliferation and invasion, and induces apoptosis of colorectal carcinoma cells.
Li Q; Shi R; Wang Y; Niu X
Tumour Biol; 2013 Feb; 34(1):505-13. PubMed ID: 23138394
[TBL] [Abstract][Full Text] [Related]
5. Functional loss of TAGLN inhibits tumor growth and increases chemosensitivity of non-small cell lung cancer.
Fu J; Wang X; Yue Q
Biochem Biophys Res Commun; 2020 Sep; 529(4):1086-1093. PubMed ID: 32819569
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
8. COMP Gene Coexpresses With EMT Genes and Is Associated With Poor Survival in Colon Cancer Patients.
Nfonsam VN; Nfonsam LE; Chen D; Omesiete PN; Cruz A; Runyan RB; Jandova J
J Surg Res; 2019 Jan; 233():297-303. PubMed ID: 30502262
[TBL] [Abstract][Full Text] [Related]
9. Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells in Vitro and in Vivo.
Tsui KH; Lin YH; Chang KS; Hou CP; Chen PJ; Feng TH; Juang HH
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591355
[TBL] [Abstract][Full Text] [Related]
10. Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT.
Chunhua L; Donglan L; Xiuqiong F; Lihua Z; Qin F; Yawei L; Liang Z; Ge W; Linlin J; Ping Z; Kun L; Xuegang S
J Nutr Biochem; 2013 Oct; 24(10):1766-75. PubMed ID: 23773626
[TBL] [Abstract][Full Text] [Related]
11. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
Fortunato A
Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
[TBL] [Abstract][Full Text] [Related]
12. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
13. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
14. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
15. USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma.
Meng J; Ai X; Lei Y; Zhong W; Qian B; Qiao K; Wang X; Zhou B; Wang H; Huai L; Zhang X; Han J; Xue Y; Liang Y; Zhou H; Chen S; Sun T; Yang C
Theranostics; 2019; 9(2):573-587. PubMed ID: 30809294
[No Abstract] [Full Text] [Related]
16. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
[TBL] [Abstract][Full Text] [Related]
17. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
Zhao J; Zhang Q; Zou G; Gao G; Yue Q
J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
[TBL] [Abstract][Full Text] [Related]
18. Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol.
Buhrmann C; Yazdi M; Popper B; Kunnumakkara AB; Aggarwal BB; Shakibaei M
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917533
[TBL] [Abstract][Full Text] [Related]
19. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]